COSI, ELISABETTA
 Distribuzione geografica
Continente #
NA - Nord America 3.138
AS - Asia 417
EU - Europa 360
AF - Africa 17
SA - Sud America 6
Totale 3.938
Nazione #
US - Stati Uniti d'America 3.134
SG - Singapore 222
CN - Cina 128
IT - Italia 115
FI - Finlandia 50
DE - Germania 46
HK - Hong Kong 35
SE - Svezia 32
FR - Francia 27
GB - Regno Unito 27
VN - Vietnam 26
RU - Federazione Russa 20
NL - Olanda 17
CI - Costa d'Avorio 16
BR - Brasile 6
IE - Irlanda 6
CH - Svizzera 5
CA - Canada 4
AT - Austria 3
CZ - Repubblica Ceca 3
IN - India 3
LT - Lituania 3
BE - Belgio 2
ES - Italia 2
EG - Egitto 1
KR - Corea 1
PH - Filippine 1
SM - San Marino 1
UA - Ucraina 1
UZ - Uzbekistan 1
Totale 3.938
Città #
Fairfield 638
Woodbridge 298
Ashburn 284
Seattle 243
Cambridge 224
Houston 215
Chandler 172
Wilmington 166
Ann Arbor 164
Singapore 138
Santa Clara 89
Boardman 66
San Diego 61
Padova 55
Medford 52
Princeton 52
Helsinki 37
Des Moines 35
Hong Kong 35
Dong Ket 26
Roxbury 24
Abidjan 16
Falkenstein 12
Beijing 9
London 8
Nanjing 8
Milan 7
Washington 7
Detroit 6
Dublin 6
Hefei 6
Nuremberg 6
Hebei 5
Jinan 5
Dronten 4
New York 4
Norwalk 4
Shenyang 4
Cervignano del Friuli 3
Dallas 3
Frankfurt am Main 3
Jiaxing 3
Kunming 3
Mainz 3
Monselice 3
Nanchang 3
Ningbo 3
Olomouc 3
Ottawa 3
Tianjin 3
Zurich 3
Angri 2
Borås 2
Castellammare di Stabia 2
Changsha 2
Chengdu 2
Chicago 2
Chiswick 2
Chongqing 2
Florence 2
Haikou 2
Ivrea 2
Los Angeles 2
Monza 2
Málaga 2
New Bedfont 2
Ogden 2
Orbetello 2
Paris 2
Pescara 2
Spinea 2
Zhengzhou 2
Acton 1
Amsterdam 1
Ancona 1
Borgo Maggiore 1
Brussels 1
Buffalo 1
Changchun 1
Chennai 1
Cidreira 1
Council Bluffs 1
Delhi 1
Duino-Aurisina 1
Franco da Rocha 1
Fulham 1
Groningen 1
Guarulhos 1
Itabira 1
Itajaí 1
Kharkiv 1
Ma'anshan 1
Manassas 1
Manaus 1
Monmouth Junction 1
Orange 1
Paranaque City 1
Perugia 1
Phoenix 1
Qingyuan 1
Totale 3.300
Nome #
Thrombotic risk correlates with mutational status in true-essential thrombocythemia 137
Polypharmacy in older people: lessons from 10 years of experience with the REPOSI register 132
Genetic analysis of erythrocytosis reveals possible causative and modifier gene mutations 130
Systemic mastocytosis and essential thrombocythemia: Case report and literature overview 130
A forgotten or minimized head trauma, rather than a mild FVII deficiency, is the most likely cause of a subdural hematoma 109
Heterozygous FXII deficiency is not associated with an increased incidence of thrombotic events: Results of a long term study 106
Hospital Care of Older Patients With COPD: Adherence to International Guidelines for Use of Inhaled Bronchodilators and Corticosteroids 105
The Dysprothrombinemias due to Arg596 Mutations: A Conundrum With No Bleeding Tendency and Venous Thrombosis due to Antithrombin Resistance 104
Complex History of the Discovery and Characterization of Congenital Factor X Deficiency. 102
Prevalence of use and appropriateness of antidepressants prescription in acutely hospitalized elderly patients 101
Need for Deprescribing in Hospital Elderly Patients Discharged with a Limited Life Expectancy: The REPOSI Study 98
Effect of busulfan on JAK2V617F allele burden. 96
Idiopathic erythrocytosis: a study of a large cohort with a long follow-up 96
Patterns of infections in older patients acutely admitted to medical wards: data from the REPOSI register 96
Prevalence, characteristics and treatment of chronic pain in elderly patients hospitalized in internal medicine wards 96
Thrombotic Events in Asymptomatic FXII Deficiency versus Symptomatic FXI Deficiency: Surprising Observations. 95
Thrombotic and Hemorrhagic Conditions Due to a Gain of Function of Coagulation Proteins: A Special Type of Clotting Disorders 95
Vitamin K-Dependent Coagulation Factors That May be Responsible for Both Bleeding and Thrombosis (FII, FVII, and FIX) 95
Thrombotic and hemorrhagic complications in idiopathic erythrocytosis 90
HFE mutations in idiopathic erythrocytosis 89
Drug–drug interactions involving CYP3A4 and p-glycoprotein in hospitalized elderly patients 89
Thrombotic events in homozygotes with a proven or highly probable Arg304Gln Factor VII mutation (FVII Padua) 1): only limited replacement therapy is needed in case of surgery 86
Mortality rate and risk factors for gastrointestinal bleeding in elderly patients 86
The story of serum prothrombin conversion accelerator, proconvertin, stable factor, cothromboplastin, prothrombin accelerator or autoprothrombin I, and their subsequent merging into factor VII 85
Thrombotic events in severe FXII deficiency in comparison with unaffected family members during a long observation period 83
Antibiotic use and associated factors in a large sample of hospitalised older people 80
Disability, and not diabetes, is a strong predictor of mortality in oldest old patients hospitalized with pneumonia 78
Prognostic relevance of glomerular filtration rate estimation obtained through different equations in hospitalized elderly patients 78
Drug-Induced Thrombophilic or Prothrombotic States: An Underestimated Clinical Problem That Involves Both Legal and Illegal Compounds 76
Sex-Differences in the Pattern of Comorbidities, Functional Independence, and Mortality in Elderly Inpatients: Evidence from the RePoSI Register 71
Living alone as an independent predictor of prolonged length of hospital stay and non-home discharge in older patients 65
Prevalence and Causes of Anemia in Hospitalized Patients: Impact on Diseases Outcome 60
African and African-American Contribution to the Knowledge of the FVII Padua (Arg304Gln) Defect 57
Acquired Isolated FVII Deficiency An Underestimated and Potentially Important Laboratory Finding. 55
Prevalence of bleeding manifestations in 128 heterozygotes for Factor X deficiency, mainly for FX Friuli, matched vs 128 unaffected family members, during a long sequential observation period (23.5 years). 52
Factor X Friuli coagulation disorder: Almost 50 Years Later 52
Congenital prothrombin defects: they are not only associated with bleeding but also with thrombosis: a new classification is needed 49
A structure–function analysis in patients with prekallikrein deficiency 46
Bleeding manifestations in heterozygotes with prothrombin deficiency or abnormalities vs. unaffected family members as observed during a long follow-up study 46
Bleeding manifestations in heterozygotes with congenital FVII deficiency: a comparison with unaffected family members during a long observation period* 46
A comment on congenital prothrombin abnormalities associated with thrombosis but not with bleeding 45
New clotting disorders that cast new light on blood coagulation and may play a role in clinical practice 44
Heparin, coumarin, protein C, antithrombin, fibrinolysis and other clotting related resistances: old and new concepts in blood coagulation 44
Myocardial Infarctions and Other Acute Coronary Syndromes in Rare Congenital Bleeding Disorders: A Critical Analysis of All Reported Cases. 43
Prevalence of hypertension and its complications in congenital Prekallikrein deficiency: analysis of all reported cases and clinical significance. 41
Increased Prevalence of Reported Cases of Congenital Prekallikrein Deficiency Among African Americans as Compared With the General Population of the United States 40
Pulmonary embolism in congenital bleeding disorders: Intriguing discrepancies among different clotting factors deficiencies 39
Cardiovascular diseases in congenital prekallikrein deficiency: Comparison with other chanceassociated morbidities 37
Role of replacement therapy in the evaluation of thrombosis occurring in congenital bleeding conditions 37
Prothrombin: Another Clotting Factor After FV That Is Involved Both in Bleeding and Thrombosis 35
null 34
Prethrombotic, prothrombotic, thrombophilic states, hypercoagulable state, thrombophilia etc.: semantics should be respected even in medical papers 30
ERYTHROCYTOSIS AND FAMILIARITY: COEXISTANCE OF MULTIPLE MUTATIONS 26
IDIOPATHIC ERYTHROCYTOSIS WITH THROMBOTIC COMPLICATIONS HAS AN ALTERED BIOMOLECULAR PROFILE 25
Ischemic strokes in congenital bleeding disorders: comparison with myocardial infarction and other acute coronary syndromes 24
Hyperglycemia at admission, comorbidities, and in-hospital mortality in elderly patients hospitalized in internal medicine wards: data from the RePoSI Registry 21
Antihypertensive treatment changes and related clinical outcomes in older hospitalized patients 18
null 9
Totale 4.034
Categoria #
all - tutte 18.275
article - articoli 17.932
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 36.207


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020308 0 0 0 0 0 0 0 0 142 57 95 14
2020/2021870 80 29 70 32 13 16 12 77 148 73 102 218
2021/2022651 3 35 52 62 43 108 10 66 67 26 32 147
2022/2023378 102 14 5 24 76 44 1 36 44 13 16 3
2023/2024287 11 37 48 29 17 37 14 12 8 5 21 48
2024/2025637 4 73 57 52 162 39 65 132 53 0 0 0
Totale 4.034